miR-4484 suppresses hepatocellular carcinoma progression via targeting KIF2C

Jianyang Lin1,2, Yun Cai3, Zhihong Chen1

  • 1Department of General Surgery, Zhenjiang First People's Hospital, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.

RNA Biology
|October 2, 2025
PubMed

Insights

MicroRNA-4484 (miR-4484) acts as a tumor suppressor in hepatocellular carcinoma (HCC) by inhibiting cell proliferation and tumor growth. It targets KIF2C, offering a potential therapeutic strategy for HCC treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Aberrant microRNA-4484 (miR-4484) expression is implicated in diseases, but its role in hepatocellular carcinoma (HCC) is understudied.
  • Hepatocellular carcinoma (HCC) is a significant global health concern with a need for novel therapeutic targets.

Purpose of the Study:

  • To investigate the function of miR-4484 in HCC progression.
  • To elucidate the regulatory relationship between miR-4484 and KIF2C in HCC.
  • To evaluate miR-4484 as a potential therapeutic agent for HCC.

Main Methods:

  • Bioinformatic analysis of TCGA-LIHC database for miR-4484 and KIF2C expression.
  • In vitro studies using HCC cell lines to assess miR-4484 effects on proliferation and cell cycle.
  • Dual-Luciferase Reporter Assays to confirm direct binding of miR-4484 to KIF2C.
  • In vivo experiments in nude mice using miR-4484 mimics to evaluate tumor growth inhibition.

Main Results:

  • miR-4484 was significantly downregulated in HCC tissues and cell lines, correlating with poor prognosis.
  • miR-4484 overexpression suppressed HCC cell proliferation and induced G1 phase arrest.
  • KIF2C was upregulated in HCC and inversely correlated with miR-4484 levels.
  • miR-4484 directly targeted KIF2C, inhibiting its expression and downstream effects.
  • In vivo administration of miR-4484 mimic significantly reduced HCC tumor growth in mice.

Conclusions:

  • miR-4484 functions as a tumor suppressor in HCC by targeting KIF2C.
  • Restoring miR-4484 levels inhibits HCC progression and tumor growth.
  • miR-4484 represents a promising therapeutic target for hepatocellular carcinoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K